Healthcare Services

Monkey Pox Testing Market Size Outlook and Demand Growth Across 2026–2030

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Monkey Pox Testing Market Over The Period 2026–2030?

The monkey pox testing market has experienced consistent expansion in recent times. Its valuation is projected to increase from $1.52 billion in 2025 to $1.59 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this historical growth include the worldwide dissemination during the 2022 outbreak, restricted diagnostic capabilities, reliance on centralized testing facilities, insufficient test kit availability, and delayed identification of cases.

The monkey pox testing market is anticipated to experience consistent expansion over the coming years. By 2030, its valuation is projected to reach $1.88 billion, demonstrating a compound annual growth rate (CAGR) of 4.3%. This projected increase is driven by factors such as the broadening of molecular testing capabilities, the growing utilization of point-of-care diagnostic tools, heightened government surveillance efforts, an increase in research funding, and advancements in rapid antigen technologies. Significant trends influencing the market during this period encompass the development of sophisticated molecular diagnostic platforms, the integration of AI for outbreak prediction and case mapping, the expansion of IoT-enabled remote testing infrastructure, the creation of high-throughput automated testing systems, and the greater incorporation of cloud-based laboratory data networks.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18817&type=smp

What Drivers Are Expected To Influence The Monkey Pox Testing Market During The Forecast Period?

The rising occurrence of monkeypox disease is anticipated to fuel the expansion of the monkey pox testing market in the future. Monkeypox is an uncommon viral illness stemming from the monkeypox virus, which belongs to the orthopoxvirus genus and is kin to the smallpox virus. The surge in monkeypox infections can be attributed to heightened human-to-human spread, international movement, and diminished immunity due to the cessation of smallpox vaccination initiatives. Testing for monkeypox is beneficial as it enables early detection of infected persons, facilitating prompt treatment and isolation to hinder further disease transmission. Furthermore, it assists in monitoring outbreaks and comprehending the virus’s modes of transmission. As an illustration, in September 2023, the World Health Organization (WHO), an intergovernmental body based in Switzerland, reported 1,131 new confirmed cases of mpox, alongside five additional related deaths, between 14 August 2023 and 11 September 2023. Consequently, the escalating prevalence of monkeypox disease is propelling the expansion of the monkey pox testing market.

How Is The Monkey Pox Testing Market Divided Into Its Major Segments?

The monkey pox testing market covered in this report is segmented –

1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies

2) By Mode: Laboratory Testing, Point Of Care Testing

3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses

Subsegments:

1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR

2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits

3) By Other Technologies: Enzyme-Linked Immunosorbent Assay (ELISA), CRISPR-Based Testing, Serological Tests (Antibody Detection)

Which Upcoming Trends Are Expected To Influence The Monkey Pox Testing Market?

Major entities within the monkey pox testing market are prioritizing the development of advanced diagnostic solutions, such as lyophilised component RT PCR kits, to improve both accessibility and reliability of testing. This lyophilised component technology involves freeze-drying reagents, allowing them to remain stable at ambient temperatures and enabling shipment without cold chain logistics. This approach reduces dependence on refrigerated storage and facilitates deployment in remote regions, all while maintaining the accuracy and dependability of the tests. For example, in August 2024, Andhra Pradesh MedTech Zone (AMTZ), an India-based facility, in collaboration with Transasia Diagnostics, launched the ErbaMDx Monkeypox RT-PCR Kit. This kit features lyophilised reagents and has received validation from the Indian Council for Medical Research (ICMR) and emergency authorization from the Central Drugs Standard Control Organisation (CDSCO). The kit boasts a 12 month shelf life and exhibits zero cross reactivity with other orthopoxviruses, ensuring highly specific detection. Its design allows for storage and transport at ambient temperature, making it ideal for remote and resource-limited settings. Ultimately, the kit aids in strengthening India’s epidemic preparedness by providing precise, reliable, and accessible mpox diagnosis, even in areas without cold chain infrastructure.

Who Are The Prominent Organizations Shaping The Monkey Pox Testing Market?

Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.

Read the full monkey pox testing market report here:

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Which Region Is Forecast To Lead The Monkey Pox Testing Market In Terms Of Market Size?

North America was the largest region in the monkey pox testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Monkey Pox Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18817&type=smp

Browse Through More Reports Similar to the Global Monkey Pox Testing Market 2026, By The Business Research Company

Zoonotic Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Eubiotics Global Market Report

https://www.thebusinessresearchcompany.com/report/eubiotics-global-market-report

Clean Label Mold Inhibitors Global Market Report

https://www.thebusinessresearchcompany.com/report/clean-label-mold-inhibitors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795